Michael Aßmann

452 total citations
11 papers, 101 citations indexed

About

Michael Aßmann is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Aßmann has authored 11 papers receiving a total of 101 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Aßmann's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Michael Aßmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers). Michael Aßmann collaborates with scholars based in Germany, United States and Spain. Michael Aßmann's co-authors include Michael Herold, R. Pasold, Kathleen Jentsch‐Ullrich, Gerd Müller, Wolfgang Knauf, Martin Mohren, Astrid Franke, Michael Koenigsmann, Volker Lakner and Dietger Niederwieser and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Michael Aßmann

11 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Aßmann Germany 5 62 56 45 29 13 11 101
Rory McCulloch United Kingdom 6 143 2.3× 116 2.1× 110 2.4× 21 0.7× 22 1.7× 17 167
Enrica Gamba Italy 3 61 1.0× 34 0.6× 52 1.2× 15 0.5× 8 0.6× 3 119
Edyta Subocz Poland 7 46 0.7× 14 0.3× 34 0.8× 15 0.5× 22 1.7× 16 88
Matthew Salzberg United States 6 87 1.4× 38 0.7× 42 0.9× 16 0.6× 15 1.2× 12 148
Fushen Sha China 4 75 1.2× 68 1.2× 44 1.0× 13 0.4× 3 0.2× 6 113
Gloria Margiotta Casaluci Italy 5 72 1.2× 60 1.1× 34 0.8× 9 0.3× 18 1.4× 11 99
Anupkumar George Australia 4 100 1.6× 65 1.2× 54 1.2× 22 0.8× 22 1.7× 6 143
Sofya Kovalchuk Italy 6 67 1.1× 47 0.8× 19 0.4× 24 0.8× 2 0.2× 17 95
Armando López Guillermo Spain 3 156 2.5× 82 1.5× 49 1.1× 34 1.2× 8 0.6× 9 169
Moulod R. El-Agnaf United Kingdom 4 34 0.5× 22 0.4× 39 0.9× 18 0.6× 21 1.6× 4 84

Countries citing papers authored by Michael Aßmann

Since Specialization
Citations

This map shows the geographic impact of Michael Aßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aßmann more than expected).

Fields of papers citing papers by Michael Aßmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Aßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aßmann. The network helps show where Michael Aßmann may publish in the future.

Co-authorship network of co-authors of Michael Aßmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Aßmann. A scholar is included among the top collaborators of Michael Aßmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Aßmann. Michael Aßmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Nielsen, Berit Dalsgaard, et al.. (2025). Early diagnosis of rheumatoid arthritis: associations between patients’ perceptions of initial symptoms and the timing of seeking help from the general practitioner. Scandinavian Journal of Rheumatology. 54(4). 242–251. 1 indexed citations
2.
Lange, Thoralf, Christian Niederwieser, Rainer Krahl, et al.. (2020). No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group. Leukemia & lymphoma. 61(12). 2821–2830. 2 indexed citations
3.
4.
Maschmeyer, Georg, Lars‐Olof Mügge, Michael Aßmann, et al.. (2015). A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010–2012. Journal of Cancer Research and Clinical Oncology. 141(9). 1639–1644. 5 indexed citations
5.
Heyn, Simone, Nadja Jäkel, Robert Rohrberg, et al.. (2012). Combined Bendamustine, Prednisone and Bortezomib (BPV) in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 120(21). 1855–1855. 2 indexed citations
6.
7.
Ridwelski, Karsten, J. Fahlke, E. Kettner, et al.. (2008). Docetaxel-cisplatin (DC) versus 5-fluorouracil-leucovorin-cisplatin (FLC) as first-line treatment for locally advanced or metastatic gastric cancer: Preliminary results of a phase III study. Journal of Clinical Oncology. 26(15_suppl). 4512–4512. 15 indexed citations
8.
Fahlke, J., Karsten Ridwelski, E. Kettner, et al.. (2007). A Multicentre Phase II Study of Docetaxel plus Cisplatin for the Treatment of Advanced Gastric Cancer. Chemotherapy. 53(6). 454–460. 6 indexed citations
9.
Hirt, Carsten, Thomas Kiefer, Antje Haas, et al.. (2006). Prognostic Significance of Quantitative t(14;18) PCR Monitoring in Advanced Stage Follicular Lymphoma Patients.. Blood. 108(11). 2757–2757. 1 indexed citations
10.
Koenigsmann, Michael, Wolfgang Knauf, Michael Herold, et al.. (2004). Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO). Leukemia & lymphoma. 45(9). 1821–1827. 33 indexed citations
11.
Herold, Michael, Michael Aßmann, A. Franke, et al.. (2000). Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial. Oncology Research and Treatment. 23(2). 164–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rory McCulloch Breakdown of academic impact, for papers by Enrica Gamba Breakdown of academic impact, for papers by Edyta Subocz Breakdown of academic impact, for papers by Matthew Salzberg Breakdown of academic impact, for papers by Fushen Sha Breakdown of academic impact, for papers by Gloria Margiotta Casaluci Breakdown of academic impact, for papers by Anupkumar George Breakdown of academic impact, for papers by Sofya Kovalchuk Breakdown of academic impact, for papers by Armando López Guillermo Breakdown of academic impact, for papers by Moulod R. El-Agnaf
Rankless by CCL
2026